SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "AMNE:(MEDICIN OCH HÄLSOVETENSKAP Medicinsk bioteknologi) ;hsvcat:3"

Sökning: AMNE:(MEDICIN OCH HÄLSOVETENSKAP Medicinsk bioteknologi) > Medicin och hälsovetenskap

  • Resultat 1-10 av 6649
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Munthe, Christian, 1962, et al. (författare)
  • The Return of Lombroso? Ethical Aspects of (Visions of) Preventive Forensic Screening
  • 2015
  • Ingår i: Public Health Ethics. - : Oxford University Press (OUP). - 1754-9973 .- 1754-9981. ; 8:3, s. 270-283
  • Tidskriftsartikel (refereegranskat)abstract
    • The vision of legendary criminologist Cesare Lombroso to use scientific theories of individual causes of crime as a basis for screening and prevention programmes targeting individuals at risk for future criminal behaviour has resurfaced, following advances in genetics, neuroscience and psychiatric epidemiology. This article analyses this idea and maps its ethical implications from a public health ethical standpoint. Twenty-seven variants of the new Lombrosian vision of forensic screening and prevention are distinguished, and some scientific and technical limitations are noted. Some lures, biases and structural factors, making the application of the Lombrosian idea likely in spite of weak evidence are pointed out and noted as a specific type of ethical aspect. Many classic and complex ethical challenges for health screening programmes are shown to apply to the identified variants and the choice between them, albeit with peculiar and often provoking variations. These variations are shown to actualize an underlying theoretical conundrum in need of further study, pertaining to the relationship between public health ethics and the ethics and values of criminal law policy.
  •  
2.
  • Falk Erhag, Hanna, et al. (författare)
  • Concluding Remarks
  • 2022
  • Ingår i: A Multidisciplinary Approach to Capability in Age and Ageing. - Chem : Springer. - 9783030780654 ; 18:2, s. 143-144
  • Bokkapitel (övrigt vetenskapligt/konstnärligt)
  •  
3.
  • Munthe, Christian, 1962 (författare)
  • Etiska aspekter på regenerativ medicin : Ethical aspects on regenerative medicine
  • 2003
  • Ingår i: SNIB-konferensen 2003, Chalmers tekniska högskola, Göteborg, 16-18 maj 2003.
  • Konferensbidrag (övrigt vetenskapligt/konstnärligt)abstract
    • Inom den regenerativa medicinen strävar man efter att ersätta skadat eller sjukligt biologiskt mänskligt material (celler, organ, kroppsdelar) med nya biologiska komponenter. Området aktualiserar en rad etiska frågeställningar vad gäller (1) produktionen av ersättningsmaterialet (t.ex. embryonala stamceller eller införskaffande av transplantationsvävnad från donatorer), (2) risker i samband med försök på människa (genmodifierat material, material från djur), samt (3) gränserna för hur långt man bör gå i denna slags försök att förlänga människans livsspann. Föredraget ger en kort översikt över dessa frågeställningar, ståndpunkter och argument i debatten kring dem.
  •  
4.
  • Palmquist, Anders, 1977, et al. (författare)
  • Complex geometry and integrated macro-porosity: Clinical applications of electron beam melting to fabricate bespoke bone-anchored implants
  • 2023
  • Ingår i: Acta Biomaterialia. - : Elsevier BV. - 1742-7061 .- 1878-7568. ; 156, s. 125-145
  • Forskningsöversikt (refereegranskat)abstract
    • The last decade has witnessed rapid advancements in manufacturing technologies for biomedical implants. Additive manufacturing (or 3D printing) has broken down major barriers in the way of producing complex 3D geometries. Electron beam melting (EBM) is one such 3D printing process applicable to metals and alloys. EBM offers build rates up to two orders of magnitude greater than comparable laser-based technologies and a high vacuum environment to prevent accumulation of trace elements. These features make EBM particularly advantageous for materials susceptible to spontaneous oxidation and nitrogen pick-up when exposed to air (e.g., titanium and titanium-based alloys). For skeletal reconstruction(s), anatomical mimickry and integrated macro-porous architecture to facilitate bone ingrowth are undoubtedly the key features of EBM manufactured implants. Using finite element modelling of physiological loading conditions, the design of a prosthesis may be further personalised. This review looks at the many unique clinical applications of EBM in skeletal repair and the ground-breaking innovations in prosthetic rehabilitation. From a simple acetabular cup to the fifth toe, from the hand-wrist complex to the shoulder, and from vertebral replacement to cranio-maxillofacial reconstruction, EBM has experienced it all. While sternocostal reconstructions might be rare, the repair of long bones using EBM manufactured implants is becoming exceedingly frequent. Despite the various merits, several challenges remain yet untackled. Nevertheless, with the capability to produce osseointegrating implants of any conceivable shape/size, and permissive of bone ingrowth and functional loading, EBM can pave the way for numerous fascinating and novel applications in skeletal repair, regeneration, and rehabilitation. Statement of significance: Electron beam melting (EBM) offers unparalleled possibilities in producing contaminant-free, complex and intricate geometries from alloys of biomedical interest, including Ti6Al4V and CoCr. We review the diverse range of clinical applications of EBM in skeletal repair, both as mass produced off-the-shelf implants and personalised, patient-specific prostheses. From replacing large volumes of disease-affected bone to complex, multi-material reconstructions, almost every part of the human skeleton has been replaced with an EBM manufactured analog to achieve macroscopic anatomical-mimickry. However, various questions regarding long-term performance of patient-specific implants remain unaddressed. Directions for further development include designing personalised implants and prostheses based on simulated loading conditions and accounting for trabecular bone microstructure with respect to physiological factors such as patient's age and disease status.
  •  
5.
  •  
6.
  • Darmanis, Spyros, et al. (författare)
  • Identification of Candidate Serum Proteins for Classifying Well-Differentiated Small Intestinal Neuroendocrine Tumors
  • 2013
  • Ingår i: PLOS ONE. - : Public Library of Science (PLoS). - 1932-6203. ; 8:11, s. e81712-
  • Tidskriftsartikel (refereegranskat)abstract
    • BackgroundPatients with well-differentiated small intestine neuroendocrine tumors (WD-SI-NET) are most often diagnosed at a metastatic stage of disease, which reduces possibilities for a curative treatment. Thus new approaches for earlier detection and improved monitoring of the disease are required.Materials and methodsSuspension bead arrays targeting 124 unique proteins with antibodies from the Human Protein Atlas were used to profile biotinylated serum samples. Discoveries from a cohort of 77 individuals were followed up in a cohort of 132 individuals both including healthy controls as well as patients with untreated primary WD-SI-NETs, lymph node metastases and liver metastases.Results A set of 20 antibodies suggested promising proteins for further verification based on technically verified statistical significance. Proceeding, we assessed the classification performance in an independent cohort of patient serum, achieving, classification accuracy of up to 85% with different subsets of antibodies in respective pairwise group comparisons. The protein profiles of nine targets, namely IGFBP2, IGF1, SHKBP1, ETS1, IL1α, STX2, MAML3, EGR3 and XIAP were verified as significant contributors to tumor classification.ConclusionsWe propose new potential protein biomarker candidates for classifying WD-SI-NET at different stage of disease. Further evaluation of these proteins in larger sample sets and with alternative approaches is needed in order to further improve our understanding of their functional relation to WD-SI-NET and their eventual use in diagnostics.
  •  
7.
  •  
8.
  • Bakidou, Anna, 1996, et al. (författare)
  • On Scene Injury Severity Prediction (OSISP) model for trauma developed using the Swedish Trauma Registry
  • 2023
  • Ingår i: BMC Medical Informatics and Decision Making. - 1472-6947. ; 23:1
  • Tidskriftsartikel (refereegranskat)abstract
    • Background: Providing optimal care for trauma, the leading cause of death for young adults, remains a challenge e.g., due to field triage limitations in assessing a patient’s condition and deciding on transport destination. Data-driven On Scene Injury Severity Prediction (OSISP) models for motor vehicle crashes have shown potential for providing real-time decision support. The objective of this study is therefore to evaluate if an Artificial Intelligence (AI) based clinical decision support system can identify severely injured trauma patients in the prehospital setting. Methods: The Swedish Trauma Registry was used to train and validate five models – Logistic Regression, Random Forest, XGBoost, Support Vector Machine and Artificial Neural Network – in a stratified 10-fold cross validation setting and hold-out analysis. The models performed binary classification of the New Injury Severity Score and were evaluated using accuracy metrics, area under the receiver operating characteristic curve (AUC) and Precision-Recall curve (AUCPR), and under- and overtriage rates. Results: There were 75,602 registrations between 2013–2020 and 47,357 (62.6%) remained after eligibility criteria were applied. Models were based on 21 predictors, including injury location. From the clinical outcome, about 40% of patientswere undertriaged and 46% were overtriaged. Models demonstrated potential for improved triaging and yielded AUC between 0.80–0.89 and AUCPR between 0.43–0.62. Conclusions: AI based OSISP models have potential to provide support during assessment of injury severity. The findings may be used for developing tools to complement field triage protocols, with potential to improve prehospital trauma care and thereby reduce morbidity and mortality for a large patient population.
  •  
9.
  • Bauzá-Thorbrügge, Marco, et al. (författare)
  • NRF2 is essential for adaptative browning of white adipocytes.
  • 2023
  • Ingår i: Redox biology. - : Elsevier. - 2213-2317. ; 68
  • Tidskriftsartikel (refereegranskat)abstract
    • White adipose tissue browning, defined by accelerated mitochondrial metabolism and biogenesis, is considered a promising mean to treat or prevent obesity-associated metabolic disturbances. We hypothesize that redox stress acutely leads to increased production of reactive oxygen species (ROS), which activate electrophile sensor nuclear factor erythroid 2-Related Factor 2 (NRF2) that over time results in an adaptive adipose tissue browning process. To test this, we have exploited adipocyte-specific NRF2 knockout mice and cultured adipocytes and analyzed time- and dose-dependent effect of NAC and lactate treatment on antioxidant expression and browning-like processes. We found that short-term antioxidant treatment with N-acetylcysteine (NAC) induced reductive stress as evident from increased intracellular NADH levels, increased ROS-production, reduced oxygen consumption rate (OCR), and increased NRF2 levels in white adipocytes. In contrast, and in line with our hypothesis, longer-term NAC treatment led to a NRF2-dependent browning response. Lactate treatment elicited similar effects as NAC, and mechanistically, these NRF2-dependent adipocyte browning responses in vitro were mediated by increased heme oxygenase-1 (HMOX1) activity. Moreover, this NRF2-HMOX1 axis was also important for β3-adrenergic receptor activation-induced adipose tissue browning in vivo. In conclusion, our findings show that administration of exogenous antioxidants can affect biological function not solely through ROS neutralization, but also through reductive stress. We also demonstrate that NRF2 is essential for white adipose tissue browning processes.
  •  
10.
  • Senkowski, Wojciech (författare)
  • High-throughput screening using multicellular tumor spheroids to reveal and exploit tumor-specific vulnerabilities
  • 2017
  • Doktorsavhandling (övrigt vetenskapligt/konstnärligt)abstract
    • High-throughput drug screening (HTS) in live cells is often a vital part of the preclinical anticancer drug discovery process. So far, two-dimensional (2D) monolayer cell cultures have been the most prevalent model in HTS endeavors. However, 2D cell cultures often fail to recapitulate the complex microenvironments of in vivo tumors. Monolayer cultures are highly proliferative and generally do not contain quiescent cells, thought to be one of the main reasons for the anticancer therapy failure in clinic. Thus, there is a need for in vitro cellular models that would increase predictive value of preclinical research results. The utilization of more complex three-dimensional (3D) cell cultures, such as multicellular tumor spheroids (MCTS), which contain both proliferating and quiescent cells, has therefore been proposed. However, difficult handling and high costs still pose significant hurdles for application of MCTS for HTS.In this work, we aimed to develop novel assays to apply MCTS for HTS and drug evaluation. We also set out to identify cellular processes that could be targeted to selectively eradicate quiescent cancer cells. In Paper I, we developed a novel MCTS-based HTS assay and found that nutrient-deprived and hypoxic cancer cells are selectively vulnerable to treatment with inhibitors of mitochondrial oxidative phosphorylation (OXPHOS). We also identified nitazoxanide, an FDA-approved anthelmintic agent, to act as an OXPHOS inhibitor and to potentiate the effects of standard chemotherapy in vivo. Subsequently, in Paper II we applied the high-throughput gene-expression profiling method for MCTS-based drug screening. This led to discovery that quiescent cells up-regulate the mevalonate pathway upon OXPHOS inhibition and that the combination of OXPHOS inhibitors and mevalonate pathway inhibitors (statins) results in synergistic toxicity in this cell population. In Paper III, we developed a novel spheroid-based drug combination-screening platform and identified a set of molecules that synergize with nitazoxanide to eradicate quiescent cancer cells. Finally, in Paper IV, we applied our MCTS-based methods to evaluate the effects of phosphodiesterase (PDE) inhibitors in PDE3A-expressing cell lines.In summary, this work illustrates how MCTS-based HTS yields potential to reveal and exploit previously unrecognized tumor-specific vulnerabilities. It also underscores the importance of cell culture conditions in preclinical drug discovery endeavors.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 6649
Typ av publikation
tidskriftsartikel (4744)
konferensbidrag (626)
doktorsavhandling (511)
forskningsöversikt (280)
annan publikation (257)
bokkapitel (145)
visa fler...
licentiatavhandling (37)
patent (16)
rapport (14)
bok (7)
samlingsverk (redaktörskap) (5)
konstnärligt arbete (4)
recension (4)
proceedings (redaktörskap) (1)
visa färre...
Typ av innehåll
refereegranskat (5344)
övrigt vetenskapligt/konstnärligt (1248)
populärvet., debatt m.m. (55)
Författare/redaktör
Thomsen, Peter, 1953 (282)
Palmquist, Anders, 1 ... (150)
Engqvist, Håkan (113)
Uhlén, Mathias (105)
Esposito, Marco, 196 ... (104)
Omar, Omar (96)
visa fler...
Persson, Cecilia (84)
Emanuelsson, Lena, 1 ... (74)
Nielsen, Jens B, 196 ... (71)
Hansson, Gunnar C., ... (69)
Shah, Furqan A. (69)
Nilsson, Peter (63)
Xia, Wei (56)
Trobos, Margarita, 1 ... (45)
Lammi, Mikko, 1961- (43)
Lausmaa, Jukka (41)
Tolmachev, Vladimir (40)
Karlsson, Niclas G., ... (39)
Landegren, Ulf (38)
Johansson, Anna, 196 ... (38)
Suska, Felicia, 1974 (38)
Löfblom, John (37)
Schwenk, Jochen M. (36)
Engqvist, Håkan, 197 ... (34)
Pontén, Fredrik (32)
Los, Marek Jan (32)
Rising, Anna (31)
Lindahl, Anders, 195 ... (31)
Johansson, Jan (30)
Kamali-Moghaddam, Ma ... (30)
Isaksson, Hanna (30)
Gatenholm, Paul, 195 ... (28)
Sandberg, Frida (28)
Tengvall, Pentti (28)
Laurell, Thomas (28)
Sundström, Birgitta (28)
Mardinoglu, Adil, 19 ... (26)
Rockberg, Johan (26)
Nilsson, Mats (25)
Felice, Pietro (25)
Nilsson, Bo (24)
Knutsson, Hans (24)
Ståhl, Stefan (24)
Wittung-Stafshede, P ... (24)
Svensson, Sara, 1981 (24)
Tenje, Maria (23)
Li, Jin-Ping (23)
Hilborn, Jöns (23)
Almqvist, Sofia, 198 ... (23)
Kingham, Paul J. (23)
visa färre...
Lärosäte
Uppsala universitet (1521)
Göteborgs universitet (1485)
Kungliga Tekniska Högskolan (915)
Karolinska Institutet (854)
Umeå universitet (825)
Chalmers tekniska högskola (765)
visa fler...
Lunds universitet (691)
Linköpings universitet (626)
Örebro universitet (275)
Stockholms universitet (256)
Sveriges Lantbruksuniversitet (188)
Malmö universitet (123)
RISE (103)
Linnéuniversitetet (102)
Karlstads universitet (69)
Högskolan i Skövde (63)
Högskolan i Borås (59)
Luleå tekniska universitet (40)
Jönköping University (33)
Mittuniversitetet (27)
Högskolan i Halmstad (22)
Gymnastik- och idrottshögskolan (17)
Högskolan Kristianstad (14)
Mälardalens universitet (13)
Högskolan Dalarna (12)
Högskolan i Gävle (11)
Södertörns högskola (10)
Högskolan Väst (5)
Blekinge Tekniska Högskola (4)
Röda Korsets Högskola (3)
Marie Cederschiöld högskola (2)
VTI - Statens väg- och transportforskningsinstitut (1)
Sophiahemmet Högskola (1)
visa färre...
Språk
Engelska (6595)
Svenska (46)
Kinesiska (2)
Tyska (1)
Ryska (1)
Odefinierat språk (1)
visa fler...
Finska (1)
Arabiska (1)
Ungerska (1)
visa färre...
Forskningsämne (UKÄ/SCB)
Naturvetenskap (1408)
Teknik (728)
Lantbruksvetenskap (85)
Samhällsvetenskap (57)
Humaniora (25)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy